Rebranding Lipophilic Excipients

Ali, Shaukat; Karpynec, Nina
September 2012
Pharmaceutical Technology Europe;Sep2012, Vol. 24 Issue 9, p8
Trade Publication
The article focuses on the rebranding of lipophilic excipeints. It says that the pharmaceutical industry relies on excipient manufacturers to design and produce excipients suitable to the dosage form and active pharmaceutical ingredients (API). It states that several excipient manufacturers are streamlining the nomenclature, structure and functionality of excipients such as stabilizers. Moreover, the rebranding reduces complexity and promote products the merits of qualities and performances.

Tags: EXCIPIENTS;  DRUG lipophilicity;  BRANDING (Marketing);  PHARMACEUTICAL industry;  DRUGS -- Dosage forms;  DRUG names;  STABILIZING agents


Related Articles

  • Recent Options for Phase 1 Formulation Development and Clinical Trial Material Supply. Kadri, Balaji V. // Pharmaceutical Technology;Aug2008 Supplement, p32 

    The article examines various methods of capsule filling which aim to improve preformulation properties, including active pharmaceutical ingredients (APIs) and binary blends. The APIs is the quickest method which offers the advantage of having little or no need for excipients, however, the method...

  • Manufacturing techniques and excipients used during the formulation of oil-in-water type nanosized emulsions for medical applications. Tamilvanan, Shunmugaperumal; Senthilkumar, Sudalaimuthu Ramachandran; baskar, Raj; Sekharan, Thenrajan Raja // Journal of Excipients & Food Chemicals;2010, Vol. 1 Issue 1, p11 

    Medically, the oil-in-water nanosized emulsions are used mainly as delivery carriers for lipophilic drug molecules which show therapeutic activity when administered via parenteral, ocular and transdermal routes. To extract multifunctional activities, the nanosized emulsions containing neutral,...

  • A validated LC Method for the Estimation of Rilpivirine in API and Pharmaceutical Dosage form. Kumar, Konda Ravi; Suneetha, A.; Srilakshmi, N. // Journal of Pharmacy Research;2012, Vol. 5 Issue 8, p4434 

    The present study describes the development of a validated LC method for the determination of rilpivirine and other pharmaceutical excipients in bulk and tablet dosage form. Chromatography was carried out on symmetry Zodiac C18 (250x4.6mm, 5μm in particle size) at ambient temperature....

  • Estimation of Olmesartan Medoxomil, an angiotensin receptor blocker in pharmaceutical dosage form by U.V. Spectrophotometric method. Parambi, Della Grace Thomas; Mathew, Molly; Jose, Anila; Revikumar, K. G. // Journal of Pharmacy Research;Aug2010, Vol. 3 Issue 8, p1706 

    A simple rapid economical accurate and precise method has been developed for estimation of Olmesartan medoxomil from tablet dosage form. The absorption maxima in THF solvent was found to be 265nm and Beer's law was obeyed in a concentration range of 5-30mcg/ml and coefficient of correlation for...

  • Formulation and Optimization of Hydrochlorothiazide Mouth Dissolving Tablets by Using Co-Processed Superdisintegrants. Jasmine Kaur Bhatia; Rupinder Kaur; Sukhdev Singh; Rajwinder Kaur // International Journal of Pharmaceutical Sciences Review & Resear;Jul/Aug2013, Vol. 21 Issue 2, p46 

    The mouth dissolving tablets (MDTs) usually dissolve in the oral cavity within 15 seconds to 3 minutes. In another words a MDT is tablet that dissolves or disintegrate in the oral cavity without the need of water or chewing. Recently formulation scientist recognized that single component...

  • Rebranding Lipophilic Excipients. Ali, Shaukat; Karpynec, Nina // Pharmaceutical Technology;Sep2012, Vol. 36 Issue 9, p8 

    The article focuses on rebranding lipophilic excipients. The basis for rebranding with the same prefix is to identify molecules by structures, functions and the applications of choice; enable the company's brand products to be recognized; and to differentiate pharmaceutical excipients from other...

  • Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. Bharate, Sonali S.; Bharate, Sandip B.; Bajaj, Amrita N. // Journal of Excipients & Food Chemicals;2010, Vol. 1 Issue 3, p3 

    Studies of active drug/excipient compatibility represent an important phase in the preformulation stage of the development of all dosage forms. The potential physical and chemical interactions between drugs and excipients can affect the chemical nature, the stability and bioavailability of drugs...

  • Recent Advances and Patents in Solid Dispersion Technology. Iqbal, Babar; Ali, Asgar; Ali, Javed; Baboota, Sanjula; Gupta, Sonal; Dang, Shweta; Muhammad, Shadab; Sahni, Jasjeet K. // Recent Patents on Drug Delivery & Formulation;Sep2011, Vol. 5 Issue 3, p244 

    High lipophilicity and high lattice energy of drugs, which result in poor solubility are major real challenges in the pharmaceutical industry for the successful development and commercialization of suitable dosage forms. Therefore various formulation strategies like complexation, lipid based...

  • Nanosuspensions: Potent vehicles for drug delivery and bioavailability enhancement of lipophilic drugs. De, Pintu Kumar; Chakraborty, Subrata; Das, Sanuj // Journal of Pharmacy Research;2012, Vol. 5 Issue 3, p1548 

    Solubility of a drug can be a limiting factor for its formulation into a suitable dosage form and it influences the effectiveness of a drug to a large extent. Nanosuspensions are defined as the sub-micron colloidal dispersions of pure drug particles stabilized by surfactants. Nanosuspensions...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics